Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Bunn, Paul

One or more keywords matched the following items that are connected to Bunn, Paul

Item Type	Name
Academic Article	Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
Academic Article	The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Academic Article	Smoking abstinence and small cell lung cancer survival. An association.
Academic Article	Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival.
Academic Article	Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites.
Academic Article	Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article	Overview of chemotherapy for small cell lung cancer.
Academic Article	A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Academic Article	Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Academic Article	Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
Academic Article	Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
Academic Article	A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Academic Article	Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Academic Article	Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
Academic Article	Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.
Academic Article	Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
Academic Article	Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Academic Article	Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Academic Article	Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Academic Article	Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Academic Article	Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
Academic Article	Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Academic Article	Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Academic Article	HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
Academic Article	Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Academic Article	Operation for stage IIIa small cell lung cancer?
Academic Article	From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
Academic Article	Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
Academic Article	Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Academic Article	Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Academic Article	EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Academic Article	Optimal therapy for elderly patients with early stage non-small cell lung cancer.
Academic Article	Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Academic Article	A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Academic Article	Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Academic Article	Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
Academic Article	Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Academic Article	A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
Academic Article	New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Academic Article	A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
Academic Article	Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: similar survival to cisplatin plus vinorelbine and less toxicity.
Academic Article	Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Academic Article	Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
Academic Article	[State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
Academic Article	CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.
Academic Article	Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
Academic Article	Ongoing and future trials of biologic therapies in lung cancer.
Academic Article	Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Academic Article	Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Academic Article	Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Academic Article	Aggressive non-Hodgkin's lymphomas in AIDS: the University of Colorado experience.
Academic Article	First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
Academic Article	Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Academic Article	Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Academic Article	EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Academic Article	Diseases desperate grown.
Academic Article	A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Academic Article	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.
Concept	Survival Rate
Concept	Cell Survival
Concept	Survival Analysis
Concept	Disease-Free Survival
Academic Article	Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.
Academic Article	Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Academic Article	Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Academic Article	Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Academic Article	Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
Academic Article	Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.
Academic Article	Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.
Grant	Lung Cancer Mutation Analysis
Grant	COLORADO BLUEPRINT--WOMEN/MINORITIES CANCER CARE TRIAL
Academic Article	Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.
Academic Article	HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Academic Article	The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
Academic Article	Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Academic Article	Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer.
Academic Article	Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
Academic Article	Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
Academic Article	2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Academic Article	Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Academic Article	Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
Academic Article	Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit.

Search Criteria

Survival